antifibrotic therapyidiopathic pulmonary fibrosispirfenidonenintendanibIPF
…ation in patients with idiopathic pulmonary fibrosis initiating antifibrotic therapy.Methods A retrospective cohort study was conducted using the 10…
4articles mentioning treatments
12treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: antifibrotic therapy ×
antifibrotic therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning antifibrotic therapy
4 articles · page 1 of 1antifibrotic therapypirfenidonenintedanibNICEIdiopathic pulmonary fibrosis (IPF)
…f updated reference equations may therefore influence access to antifibrotic therapy and should be considered when interpreting spirometry-based eli…
antifibrotic therapyNintedanibPirfenidoneIdopathetic Pulmonary Fibrosis (IPF)Progressive Fibrosis Interstitial Lung Diseases (PFILD)UK tertiary centreischaemic heart disease
…atient characteristics, clinical features, initiation dosing on antifibrotic therapy tolerance. This table shows statistical association between bas…
86.6%
Antifibrotic therapynintedanibmycophenolateidiopathic pulmonary fibrosistertiary hospitalDiffuse interstitial lung diseases (DILD)sclerodermaPFLDIPFprogressive fibrosing lung disease (PFLD)
…, may evolve into a fibrotic phenotype with functional decline. Antifibrotic therapy, particularly nintedanib, has significantly improved management…